Drug interaction summaries have now been added for all interactions where further information is available.
This new feature summarises key data from SPCs, Prescribing Information and published studies. Details of the direction and magnitude of the interaction and any management recommendations are given. These summaries will form the basis of the new PDA version of the charts which will be launched later this month.
